Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
about
A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric ResearchDecoding the non-coding genome: elucidating genetic risk outside the coding genomeMolecular neurobiological clues to the pathogenesis of bipolar disorderRNA Sequencing in SchizophreniaSystematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.Olfactory Neuroepithelial Neural Progenitor Cells from Subjects with Bipolar I Disorder.Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia.Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree.Reduced CYFIP1 in Human Neural Progenitors Results in Dysregulation of Schizophrenia and Epilepsy Gene Networks.Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunitiesConcise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.Innovative approaches to bipolar disorder and its treatmentDisease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders.Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.Modeling psychiatric disorders with patient-derived iPSCs.Pluripotent stem cells in disease modelling and drug discovery.An update on stem cell biology and engineering for brain development.Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular ActionsThe promises and challenges of human brain organoids as models of neuropsychiatric disease.Update on bipolar disorder biomarker candidates.Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons.Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence.Disease modelling using human iPSCs.Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.Modeling neurodevelopmental and psychiatric diseases with human iPSCs.Pluripotent stem cells in neuropsychiatric disorders.Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.Human induced pluripotent stem cells for modelling neurodevelopmental disorders.Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic ImplicationsMolecular genetics and targeted therapy of WNT-related human diseases (Review).Chemokine and Chemokine Receptor Polymorphisms in Bipolar DisorderUnraveling the biology of bipolar disorder using induced pluripotent stem-derived neurons.The use of brain organoids to investigate neural development and disease.Personalized medicine in a dish: the growing possibility of neuropsychiatric disease drug discovery tailored to patient genetic variants using stem cells.
P2860
Q26770097-174A6C1E-7395-4D96-9F05-4B4F1C07AB47Q26777924-196E8822-E9A0-4C77-9021-8F7B73BC57E7Q26799513-E0E2B7CD-AE95-441D-86DD-1F33B63507EFQ26996831-B9E409EA-3130-46D2-A29F-1198E09AF641Q30234571-D5457877-3578-4263-A874-3EC01DF139CCQ33565978-3D85B00B-004C-4318-B68A-094F9D787BB7Q33703849-5A3D3A84-10D7-4E23-A619-A7E002479C5BQ33782489-B925CE77-F5B2-4C70-A6C6-AC246D8262D0Q35837073-046F6B3D-D1CE-4DCF-8F75-548489AE756DQ36519585-F6D4455E-C20D-4EC8-A530-B4764196CCBCQ36535520-3FEDAD2C-5959-4AE1-AC31-B35B485EFA46Q36717285-F99C6AA8-6445-41E6-9D7D-140CB79B19CCQ36851161-0A8D42C0-1C46-45CE-A04C-4C624D1F2E31Q36902087-7994DD8B-1391-44D6-B316-BC5454AC06ADQ37344763-AA9890F5-CAE2-4751-A79D-F45A3CE4525CQ37624658-020C133D-AF6C-40FE-BA40-F0AC0BDE0879Q37639334-05936A8D-EB3B-44D1-B81C-1A2D0BFE2745Q38679839-0053E7EA-6F08-43CF-8E83-F8B05BE40CE0Q38714328-0634472B-6B57-4E39-8E19-A22FE6734CE5Q38735486-B924F5C9-1433-4A3C-BC0B-96F0596EB444Q38770806-6EBB6DEF-3EE4-4689-9B94-30CC986E66D8Q38802467-534FF306-B84F-448C-B123-A83F1A8FB927Q38803583-4932142E-06E5-481D-B268-BFDB2234FE91Q38806729-447AFB87-7E70-4A4F-94D5-D99E660F8A4CQ38807798-325B8579-4182-4723-AF37-4C4FF72E9F09Q38809416-1EE58019-CC38-4058-ABEB-6854DD12E889Q38919220-4EC64419-80EA-428C-9721-984BBA034B9EQ38957224-AB7BC577-69C8-4487-A56A-BCEE7612F281Q38964644-6CA7BAA6-DE56-4A6C-BCCA-368B1EC55503Q39130188-2065C203-9D54-446B-BD2B-57B0834BC14FQ39189500-56EF2C72-D169-4439-9959-2ED05AEA7B3FQ39202144-72AA4503-0FB9-45F9-A788-DA58C5318803Q39231042-027791BA-8ACE-4F04-A16B-9C3533017E0BQ39247913-C31624E4-03D8-4DF1-BB94-146ADBB5053EQ39267337-9D763A10-0E19-49EC-975F-479B10CE7393Q39450241-715F7791-032A-4215-94B7-667014E6E685Q41481938-3360074F-05AD-4835-AA72-C5887AE07D8EQ46001572-228CD388-CD2D-460F-BC30-B8F20A639D23Q46137846-05137A58-D75F-4C88-9E61-AD65917BEC60Q47165819-0E9AB3D3-3296-4C7D-8BDB-4B3026D99913
P2860
Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of bipolar di ...... mRNA expression abnormalities.
@ast
Characterization of bipolar di ...... mRNA expression abnormalities.
@en
type
label
Characterization of bipolar di ...... mRNA expression abnormalities.
@ast
Characterization of bipolar di ...... mRNA expression abnormalities.
@en
prefLabel
Characterization of bipolar di ...... mRNA expression abnormalities.
@ast
Characterization of bipolar di ...... mRNA expression abnormalities.
@en
P2093
P2860
P356
P1433
P1476
Characterization of bipolar di ...... mRNA expression abnormalities.
@en
P2093
C O'Dushlaine
D D Barker
E H Rueckert
J M Madison
P2860
P2888
P304
P356
10.1038/MP.2015.7
P407
P577
2015-03-03T00:00:00Z
P5875
P6179
1009930014